SCHEMBL21733792

SCHEMBL21733792

COc1ccc(CN(Cc2ccc(OC)cc2)c2cc(C)c(C(F)(F)F)c(C3=CC(=O)CCC3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.35
PIK3CD O00329 2/20 0.35
MAPT P10636 2/20 0.35
PIK3R2 O00459 1/20 0.35
PIK3CG P48736 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ALDH1A1 P00352 2/20 0.34
TSHR P16473 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
FABP4 P15090 3/20 0.34
FABP3 P05413 1/20 0.33
F10 P00742 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
PDE2A O00408 1/20 0.31
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21733720 0.83 ALDH1A1 (0.35) LMNAPIK3CDMAPTSMN1; SMN2L3MBTL1
SCHEMBL21733451 0.82 LMNA (0.33) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL21733481 0.81 ALDH1A1 (0.36) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL21733539 0.80 ALDH1A1 (0.34) LMNAMAPTHTTSMN1; SMN2L3MBTL1
SCHEMBL29384926 0.76 LMNA (0.37) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL21733449 0.76 LMNA (0.37) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL21734048 0.76 PIK3CD (0.42) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL31196081 0.76 PIK3CA (0.37) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL31380892 0.75 PIK3CD (0.36) LMNAPIK3CDMAPTPIK3R2PIK3CG
SCHEMBL30142533 0.74 TSPO (0.39) MAPTSMN1; SMN2ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760744-B2 Fused ring compounds GENENTECH, INC. (US) 2023-09-19 US disclosed
US-11760744-B2 Fused ring compounds GENENTECH, INC. (US) 2023-09-19 US disclosed
US-20230002345-A1 FUSED RING COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-01-05 US disclosed
WO-2020035031-A1 FUSED RING COMPOUNDS GENENTECH, INC. (US) 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760744-B2 Fused ring compounds KRAS, NRAS, HRAS LMNA 3608/4885PIK3CD 506/4885MAPT 3269/4885
US-20230002345-A1 FUSED RING COMPOUNDS KRAS, NRAS, HRAS LMNA 3608/4885PIK3CD 506/4885MAPT 3269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.